Skip to main content
Onesource Specialty Pharma Limited logo

Onesource Specialty Pharma Limited — Investor Relations & Filings

Ticker · ONESOURCE ISIN · INE013P01021 LEI · 335800TP5C932B9IQT98 BSE.NS Manufacturing
Open in API
Filings indexed 156 across all filing types
Latest filing 2025-11-18 Regulatory Filings
Country IN India
Listing BSE.NS ONESOURCE

About Onesource Specialty Pharma Limited

https://www.onesourcecdmo.com/

Onesource Specialty Pharma Limited is a specialized Contract Development and Manufacturing Organization (CDMO) providing integrated solutions for complex pharmaceutical products. The company focuses on the development and large-scale manufacturing of specialty injectables, softgel capsules, and complex formulations. Its service portfolio encompasses the entire product lifecycle, including formulation development, clinical trial supply, and commercial-stage production. Onesource operates advanced manufacturing facilities designed to meet global regulatory standards, catering to diverse therapeutic areas. By leveraging technical expertise in sterile products and differentiated dosage forms, the organization supports global pharmaceutical partners in bringing high-entry-barrier medicines to market. The platform is built on a foundation of quality compliance and operational excellence to ensure the delivery of critical healthcare solutions.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the company's non-participation in a scheduled investor conference. It references a prior intimation but does not contain any financial data, report, or detailed presentation. The length is only 1559 characters, which is quite short and does not constitute a full report or detailed filing. This is an announcement related to investor relations but does not fit into categories like Investor Presentation or Earnings Release since it is merely a notification of non-participation. It is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-11-18 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the company's participation in an upcoming investor conference (Jefferies Global Healthcare Conference). It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations for listed companies. The content is an announcement of an event involving investor engagement and does not contain any financial data, report, or detailed presentation. The document length is only 1886 characters, which is quite short and fits the pattern of a regulatory announcement rather than a full report or presentation. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-11-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short communication dated November 13, 2025, addressed to stock exchanges, informing about the availability of the audio recording of an earnings call held on November 12, 2025. It references unaudited financial results for the quarter and half year ended September 30, 2025, but does not contain any financial data or analysis itself. The document is essentially an announcement about the earnings call audio recording being posted on the company's website. Given the short length (1706 characters) and the nature of the content (announcement of an earnings call recording), it is not the earnings release itself nor the full call transcript. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other categories.
2025-11-13 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of un-audited financial results for the quarter and half year ended September 30, 2025. It mentions that the information is published as a newspaper advertisement pursuant to SEBI regulations. The document itself is short (2207 characters) and primarily serves as a notification of the publication of financial results, not the full financial report or detailed financial statements. Therefore, it is an announcement related to financial results rather than the results themselves. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement and does not contain substantive financial data or detailed financial analysis itself.
2025-11-13 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Earnings presentation (Q2FY26)' and includes detailed financial performance data for the quarter Q2FY26, including revenue, EBITDA, PAT, and EPS figures. It also contains operational updates, business highlights, acquisition progress, and forward-looking statements. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. The presence of detailed financial metrics and business strategy updates aligns with the characteristics of an Investor Presentation. There is no indication that this is a full Annual Report, Audit Report, or Earnings Release (which typically are shorter and more focused on key financial results). The document is explicitly called an 'Earnings presentation' and includes slides and detailed commentary, which fits the definition of an Investor Presentation (IP).
2025-11-12 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated November 11, 2025, announcing the company's Q2FY26 financial performance with revenue growth and margin expansion. It includes key financial highlights such as revenues, EBITDA, adjusted PAT, and EPS for the quarter and half-year periods. The document is relatively short (4630 characters) and is titled as a 'Press Release'. It does not contain detailed financial statements or comprehensive analysis typical of an Interim/Quarterly Report (IR). Instead, it provides summarized financial results and commentary from the CEO. This matches the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only. Therefore, the appropriate classification is ER with high confidence.
2025-11-11 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.